［1］SHARMA S.Drugs for parasitic diseases ［J］.Drug Today，1989，25(4):249.
［2］DANIEL-MWAMBETE K，TORRADO S，CUESTA-BANDERA C，et al.The effect of solubilization on the oral bioavailability of three benzimidazole carbamate drugs［J］.Int J Pharm，2004，272(1-2):29-36.
［3］JUNG H，MEDINA L，GARCÉA L，et al.Absorption studies of albendazole and some physicochemical properties of the drug and its metabolite albendazole sulphoxide［J］.J Pharm Pharmacol，1998，50(1):43-48.
［4］VOGT M，KUNATH K，DRESSMAN J B.Dissolution improvement of four poorly water soluble drugs by cogrinding with commonly used excipients［J］.Eur J Pharm Biopharm，2008，68(2):330-337.
［5］KATA M，SCHAUER M.Increasing the solubility characteristics of albendazole with dimethyl-beta-cyclodextrin［J］.Acta Pharm Hung,1991，61(1)：23-31.
［6］SAVIO E，DOMÉNGUEZ L，MALANGA A，et al.Lipidic matrix of albendazole：an alternative for systemic infections［J］.Boll Chim Farm,1998，137(9)：345-349.
［7］LOPEZ M L，TORRADO S，MARTÉNEZ A R，et al.Improvement of albendazole efficacy against enteral，but not against parenteral stages of Trichinella spiralisby preparing solid dispersions in polyvinylpyrrolidone［J］.Chemotherapy，1997,43(6)：430-435.
［8］KOHRI N，YAMAYOSHI Y，XIN H，et al.Improving the oral bioavailability of albendazole in rabbits by the solid dispersion technique［J］.J Pharm Pharmacol，1999，51(2)：159-164.
［9］CASTRO S G，BRUNI S S，LANUSSE C E，et al.Improved albendazole dissolution rate in pluronic 188 solid dispersions［J］.AAPS Pharm Sci Tech，2010,11(4)：1518-1525.
［10］徐晓弘，翟所迪.阿苯达唑固体分散物制备及体外溶出特性研究［J］.中国药学杂志，2002，37（4）:283-286.
［11］CASTRO S G，SANCHEZ BRUNI S F，URBIZU L P，et al.Enhanced dissolution and systemic availability of albendazole formulated as solid dispersions［J］.Pharm Dev Technol，2013，18(2)：434-442.
［12］LEUNER C，DRESSMAN J.Improving drug solubility for oral delivery using solid dispersions［J］.Eur J Pharm Biopharm，2000，50(1)：47-60.
［13］HIGUCHI T，CONNORS K A．Phase solubility techniques ［J］．Adv Anal Chem Instrum，1965，4(1)：117-212．
［14］FORD J L.The current status of solid dispersions ［J］.Pharm Acta Helv，1986，61(3):69-88.
［15］朱盛山.药物新剂型［M］.北京：化学工业出版社，2003：23-26.
［16］VERHEYEN S，BLATON N，KINGET R，et al.Mechanism of increased dissolution of diazepam and temazepam from polyethylene glycol 6000 solid dispersions［J］.Int J Pharm，2002，249(1-2):45-58.
［17］CRAIG D Q.The mechanisms of drug release from solid dispersions in water-soluble polymers［J］.Int J Pharm，2002，231(2):131-144.
［18］MURA P，MANDERIOLI A，BRAMANTI G，et al.Properties of solid dispersions of naproxen in various polyethylene glycols ［J］. Drug Dev Ind Pharm，1996，22(9-10):909-916.
［19］ZERROUK N，CHEMTOB C，ARNAUD P，et al.In vitro and in vivo evaluation of carbamazepine-PEG 6000 solid dispersions ［J］.Int J Pharm，2001，225(1-2)：49-62.
［20］PARADKAR A，AMBIKE A A，JADHAV B K，et al.Characterization of curcumin-PVP solid dispersion obtained by spray drying ［J］.Int J Pharm，2004，271(1-2)：281-286.
［21］张光宇，晏语，倪进，等.阿苯达唑-壳聚糖微球的制备及其质量指标的考察［J］.抗感染药学，2012，9(2):108-114.
［22］孙淑英.聚合物载体在固体分散物中的应用［J］.沈阳药学院学报，1991，8(1):67-72.